Glial Cell Line-Derived Neurotrophic Factor
Also known as: GDNF
Descripton
Glial Cell Line-Derived Neurotrophic Factor is a type of endogenous Neurotropic Factor, first identified in 1993.
Potential Therapeutic Benefits of GDNF
Nervous System
GDNF may improve the survival of Dopaminergic Neurons (Neurons that use Dopamine as a Neurotransmitter) in the Substantia Nigra of the Brain.
GDNF is a promising potential therapy for regenerating damaged Nerves (it is speculated to function as an “attractor” for regenerating Axons).
GDNF is a promising potential therapy for Parkinson's Disease (due to its ability to prolong the survival of Dopaminergic Neurons in the Substantia Nigra of the Brain): [1]
You have read 30% of this topic
Keep reading Glial Cell Line-Derived Neurotrophic Factor
- GDNF Enhances the Function of these Substances
- Neurotransmitters
- These Substances may Facilitate the Production of GDNF
- Hormones
- Smart Drugs
- Vitamins
- 4 more sections
- Every cited reference behind this topic
- All 5,000+ interlinked topics, search and notes
No credit card needed to start a trial. Already a member? Log in